Coherus BioSciences, Inc. (CHRS)

NASDAQ: CHRS · IEX Real-Time Price · USD

1.640

+0.070 (4.46%)

At close: Jul 19, 2024, 4:00 PM

1.670

+0.030 (1.83%)

Pre-market: Jul 22, 2024, 6:04 AM EDT

Coherus BioSciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	2018 - 2012
Revenue	301.87	257.24	211.04	326.55	475.82	356.07	Upgrade
Revenue Growth (YoY)	64.63%	21.89%	-35.37%	-31.37%	33.63%	-	Upgrade
Cost of Revenue	176.7	158.99	70.08	57.59	37.67	17.08	Upgrade
Gross Profit	125.17	98.25	140.96	268.96	438.16	338.99	Upgrade
Selling, General & Admin	199.39	192.02	198.48	169.71	139.08	137.04	Upgrade
Research & Development	103.75	109.44	199.36	363.11	142.76	94.19	Upgrade
Operating Expenses	303.15	301.45	397.84	532.82	281.84	231.23	Upgrade
Operating Income	-177.98	-203.2	-256.88	-263.86	156.32	107.77	Upgrade
Interest Expense / Income	41.95	40.54	32.47	22.96	21.17	17.6	Upgrade
Other Expense / Income	-160.26	-5.47	2.4	0.28	-0.55	-2.61	Upgrade
Pretax Income	-59.67	-238.27	-291.75	-287.1	135.71	92.78	Upgrade
Income Tax	-0.38	-0.38	0	0	3.46	2.94	Upgrade
Net Income	-59.29	-237.89	-291.75	-287.1	132.24	89.83	Upgrade
Net Income Growth	-	-	-	-	47.21%	-	Upgrade
Shares Outstanding (Basic)	113	94	78	75	71	70	Upgrade
Shares Outstanding (Diluted)	126	94	78	75	71	73	Upgrade
Shares Change	58.36%	21.30%	2.89%	5.65%	-2.42%	12.53%	Upgrade
EPS (Basic)	-0.73	-2.53	-3.76	-3.81	1.85	1.29	Upgrade
EPS (Diluted)	-0.81	-2.53	-3.76	-3.81	1.62	1.23	Upgrade
EPS Growth	-	-	-	-	31.71%	-	Upgrade
Free Cash Flow	-152.39	-174.33	-243.16	-38.72	147.09	26.53	Upgrade
Free Cash Flow Per Share	-1.35	-1.85	-3.13	-0.51	2.06	0.38	Upgrade
Gross Margin	41.46%	38.19%	66.79%	82.36%	92.08%	95.20%	Upgrade
Operating Margin	-58.96%	-78.99%	-121.72%	-80.80%	32.85%	30.27%	Upgrade
Profit Margin	-19.64%	-92.48%	-138.24%	-87.92%	27.79%	25.23%	Upgrade
Free Cash Flow Margin	-50.48%	-67.77%	-115.22%	-11.86%	30.91%	7.45%	Upgrade
Effective Tax Rate	-	-	-	-	2.55%	3.17%	Upgrade
EBITDA	-10.9	-191.46	-253.08	-258.48	159.76	115.42	Upgrade
EBITDA Margin	-3.61%	-74.43%	-119.92%	-79.15%	33.58%	32.42%	Upgrade
Depreciation & Amortization	6.83	6.27	6.2	5.66	2.89	5.05	Upgrade
EBIT	-17.72	-197.73	-259.28	-264.14	156.87	110.38	Upgrade
EBIT Margin	-5.87%	-76.86%	-122.86%	-80.89%	32.97%	31.00%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).